Upgrade to SI Premium - Free Trial

Surgery Partners (SGRY) Reiterated at Overweight by Cantor Fitzgerald After HCIT Survey

April 15, 2026 7:39 AM
Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $25.00 price target on Surgery Partners (NASDAQ: SGRY).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments